Systematic review / meta-analysis / 2016
Metformin use was linked to significantly lower serum vitamin B12 levels in patients with type 2 diabetes.
A systematic review and meta-analysis of 26 papers evaluated the link between metformin use and vitamin B12 deficiency in type 2 diabetes. Ten of 17 observational studies reported statistically significantly lower vitamin B12 levels in patients taking metformin compared to those not taking it. A meta-analysis of four trials found a statistically significant mean B12 reducing effect of metformin of 57 pmol/L [WMD (fixed) = -0.57 (95% CI: -35 to -79 pmol/L)] after 6 weeks to 3 months of use.
- Study type
- Systematic review and meta-analysis
- Who was studied
- Patients with type 2 diabetes of any age or gender (26 papers included)
- What was measured
- Serum vitamin B12 levels, % prevalence/incidence, and risk of vitamin B12 deficiency
THE PAPER
Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis.
Chapman LE, Darling AL, Brown JE. Diabetes Metab, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.